查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1962092

全球感染疾病監測解決方案市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Infection Surveillance Solutions Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，感染疾病監測解決方案市場規模將達到 2,360,890,000 美元，高於 2025 年的 755,290,000 美元，預計從 2026 年到 2034 年的複合年成長率將達到 13.5%。

受醫療機構對有效感染控制和預防策略日益成長的需求所推動，感染疾病監測解決方案市場預計將迎來顯著成長。隨著全球醫療相關感染（HAI）負擔持續加重，醫療機構正優先部署強大的監測系統，以監測和管理疫情爆發。這些解決方案使醫療服務提供者能夠收集、分析和報告感染率數據，從而促進及時介入並提高病人安全。數據分析、人工智慧和機器學習領域的創新正在增強感染監測系統的功能，使其能夠進行即時監測和預測分析，從而在疫情擴散之前識別潛在爆發點。

此外，對監管合規和品質改進日益重視正在影響感染疾病監測解決方案市場。醫療機構越來越需要遵守監管機構制定的嚴格指南和報告標準，這推動了對確保合規性的全面監測解決方案的需求。此外，以價值為導向的醫療模式的興起促使醫療服務提供者更加重視改善患者預後和降低感染相關成本，從而進一步加速了感染監測技術的應用。

此外，新冠肺炎疫情凸顯了感染監測在公共衛生危機管理中的重要性。有效追蹤和報告感染疾病的需求促使人們增加對監測技術的投資，不僅在醫院，也在公共衛生機構。與行動醫療應用和遠端醫療平台的整合也提高了感染監測解決方案的可近性和效率，使醫療服務提供者能夠即時監測感染趨勢並快速應對新出現的威脅。總之，感染疾病監測解決方案市場預計將迎來強勁成長，其特點是技術進步、注重合規以及致力於提高病患安全和公共衛生水準。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球感染疾病監測解決方案市場：依產品及服務分類

  • 市場分析、洞察與預測
  • 軟體
  • 服務

第5章 全球感染疾病監測解決方案市場：依感染類型分類

  • 市場分析、洞察與預測
  • 手術部位感染
  • 血液感染
  • 尿道感染

第6章 全球感染疾病監測解決方案市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 門診手術中心

第7章 全球感染疾病監測解決方案市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • PremierInc
    • Wolters Kluwer NV
    • Cerner Corporation（Oracle）
    • RLDatix
    • VigiLanz Corporation
    • GOJO IndustriesInc
    • Baxter International Inc
    • BioMAfA（C）Rieux SA
    • IBM Corporation（Merative）
    • Epic Systems Corporation
    • Theradoc（Premier Inc.）
    • BioVigil Healthcare SystemsInc
    • Ecolab Inc
    • AsolvaInc
簡介目錄
Product Code: VMR112115391

The Infection Surveillance Solutions Market size is expected to reach USD 2360.89 Million in 2034 from USD 755.29 Million (2025) growing at a CAGR of 13.5% during 2026-2034.

The infection surveillance solutions market is poised for significant growth, driven by the increasing need for effective infection control and prevention strategies in healthcare settings. As the global burden of healthcare-associated infections (HAIs) continues to rise, healthcare facilities are prioritizing the implementation of robust surveillance systems to monitor and manage infection outbreaks. These solutions enable healthcare providers to collect, analyze, and report data on infection rates, facilitating timely interventions and improving patient safety. Innovations in data analytics, artificial intelligence, and machine learning are enhancing the capabilities of infection surveillance systems, allowing for real-time monitoring and predictive analytics that can identify potential outbreaks before they escalate.

Moreover, the growing emphasis on regulatory compliance and quality improvement initiatives is influencing the infection surveillance solutions market. Healthcare organizations are increasingly required to adhere to stringent guidelines and reporting standards set by regulatory bodies, driving the demand for comprehensive surveillance solutions that ensure compliance. Additionally, the rise of value-based care models is prompting healthcare providers to focus on improving patient outcomes and reducing costs associated with infections, further fueling the adoption of infection surveillance technologies.

Furthermore, the COVID-19 pandemic has underscored the importance of infection surveillance in managing public health crises. The need for effective tracking and reporting of infectious diseases has led to increased investments in surveillance technologies, not only in hospitals but also in public health agencies. The integration of mobile health applications and telehealth platforms is also enhancing the accessibility and efficiency of infection surveillance solutions, enabling healthcare providers to monitor infections in real-time and respond swiftly to emerging threats. In summary, the infection surveillance solutions market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to improving patient safety and public health.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products and Services

  • Software
  • Services

By Infection Type

  • Surgical Site Infections
  • Blood Stream Infections
  • Urinary Tract Infections

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

COMPANIES PROFILED

  • Becton, Dickinson and Company BD, , Premier, Inc, Wolters Kluwer NV, Cerner Corporation Oracle, RLDatix, VigiLanz Corporation, GOJO Industries, Inc, Baxter International Inc, bioMrieux SA, IBM Corporation Merative, Epic Systems Corporation, Theradoc Premier Inc, bioVigil Healthcare Systems, Inc, Ecolab Inc, Asolva, Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY PRODUCTS AND SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Products And Services
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY INFECTION TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Infection Type
  • 5.2. Surgical Site Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Blood Stream Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Urinary Tract Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Products And Services
    • 7.2.2 By Infection Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Products And Services
    • 7.3.2 By Infection Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Products And Services
    • 7.4.2 By Infection Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Products And Services
    • 7.5.2 By Infection Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Products And Services
    • 7.6.2 By Infection Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INFECTION SURVEILLANCE SOLUTIONS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 PremierInc
    • 9.2.2 Wolters Kluwer N.V
    • 9.2.3 Cerner Corporation (Oracle)
    • 9.2.4 RLDatix
    • 9.2.5 VigiLanz Corporation
    • 9.2.6 GOJO IndustriesInc
    • 9.2.7 Baxter International Inc
    • 9.2.8 BioMAfA(C)Rieux SA
    • 9.2.9 IBM Corporation (Merative)
    • 9.2.10 Epic Systems Corporation
    • 9.2.11 Theradoc (Premier Inc.)
    • 9.2.12 BioVigil Healthcare SystemsInc
    • 9.2.13 Ecolab Inc
    • 9.2.14 AsolvaInc